FDA Revokes Orphan Drug Designation for Opioid Addiction Treatment

Drug Industry Daily
A A
The FDA has revoked Indivior’s orphan drug designation for its opioid addiction treatment Sublocade (buprenorphine extended-release injection) finding that it was improperly granted.

To View This Article:

Login

Subscribe To Drug Industry Daily